NDA 021261 · Medtech Products
Monistat 3 Combination Pack
Miconazole Nitrate · Topical, Vaginal
Last checked: Nov 20, 2026Latest source record: Jul 22, 2020 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2001
Feb 2, 2001
Approved uses
1
Original approval plus efficacy supplements
Registered trials
36
8 Phase 3, 0 recruiting
FAERS reports
2,640
800 serious, 86 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Oct 27, 2025.
Uses treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
2 products under this application
- MONISTAT 3 COMBINATION PACK · MICONAZOLE NITRATE 2%,4% · CREAM, TOPICAL, VAGINAL · Over-the-counter
- MONISTAT 3 COMBINATION PACK (PREFILLED) · MICONAZOLE NITRATE 2%,4% · CREAM, TOPICAL, VAGINAL · Over-the-counter
Clinical trials
Interventional ClinicalTrials.gov studies with "Miconazole Nitrate" as an intervention, any sponsor and status, largest first.
- Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious VaginitisPivotal-lookingCompleted
Laboratoire Innotech InternationalIndustry
NCT02515656 · 661 participants · Start Sep 2015 · Primary completion Aug 2016
Drug: POLYGYNAX®; GYNODAKTARIN® and 1 more · For: Vaginitis
Sites: Prague, Czechia; Lyon, France; Belgrade, Serbia · 4 sites in all
- An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's FootPivotal-lookingTerminated
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Johnson & Johnson (Janssen) (JNJ)
NCT01110330 · 583 participants · Start Jul 2007 · Primary completion Oct 2008
Drug: Placebo cream; Ketoconazole 2% cream (formulation F012) (Nizoral) and 1 more · For: Tinea Pedis
Sites: Bydgoszcz, Poland; Lodz, Poland; Lublin, Poland · 11 sites in all
- Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV PatientsPivotal-lookingCompleted
Valerio TherapeuticsIndustry
NCT00390780 · 578 participants · Start Jul 2006 · Primary completion Dec 2007
Drug: miconazole Lauriad; Clotrimazole · For: HIV Infections
Sites: Birmingham, Alabama; Los Angeles, California; Oakland, California · 27 sites in all
- Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)Pivotal-lookingCompleted
Hill Dermaceuticals, Inc.Industry
NCT04432376 · 382 participants · Start Jul 8, 2020 · Primary completion Nov 1, 2021
Drug: miconazole 2% oil; vehicle oil · For: Otomycosis
Sites: Chula Vista, California; La Jolla, California; Roseville, California · 12 sites in all
- Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative WomenPivotal-lookingCompleted
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT01230814 · 234 participants · Start Apr 2011 · Primary completion Aug 2013
Drug: Neo-Penotran® Forte (active ingredient Metronidazole & Miconazole Nitrate); Placebo · For: Bacterial Vaginosis; Candidiasis; Trichomoniasis
Sites: Birmingham, Alabama; Mombasa, Kenya; Nairobi, Kenya · 4 sites in all
Stiefel, a GSK CompanyIndustry
NCT00702507 · 200 participants · Start May 2007 · Primary completion Dec 2010
Drug: 0.25 % Miconazole Nitrate Ointment · For: Diaper Rash
Sites: San Diego, California; Coral Gables, Florida; Miami, Florida · 8 sites in all
- Validation of a Novel Diagnostic, Prognostic Assay for Bacterial VaginosisPivotal-lookingStatus unknown
Wayne State UniversityAcademic, hospital or other
NCT02185456 · 200 participants (planned) · Start Sep 2014 · Primary completion Jan 2016
Drug: 750 mg metronidazole/ 200 mg miconazole vaginal suppository; Standard of care · For: Bacterial Vaginosis
Sites: Detroit, Michigan
- Comparative Study of Topical Oxiconazole 1% Cream Versus Clotrimazole 1% Cream in the Treatment of DermatophytosisPivotal-lookingCompleted
Shalamar Institute of Health SciencesAcademic, hospital or other
NCT07718685 · 164 participants · Start Jan 1, 2025 · Primary completion Jun 30, 2025
Drug: Oxiconazole Nitrate Cream; Clotrimazole Cream · For: Dermatophytoses
Sites: Lahore, Pakistan
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- vulvovaginal burning sensation742
- vulvovaginal pain525
- drug ineffective313
- vulvovaginal pruritus253
- vaginal haemorrhage235
- vulvovaginal discomfort192
- condition aggravated179
- vulvovaginal swelling155
- pain102
- pruritus74
- abdominal pain71
- hypersensitivity69
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 14 |
| 2005 | 20 |
| 2006 | 20 |
| 2007 | 13 |
| 2008 | 36 |
| 2009 | 66 |
| 2010 | 42 |
| 2011 | 46 |
| 2012 | 73 |
| 2013 | 16 |
| 2014 | 23 |
| 2015 | 31 |
| 2016 | 122 |
| 2017 | 112 |
| 2018 | 202 |
| 2019 | 196 |
| 2020 | 207 |
| 2021 | 264 |
| 2022 | 243 |
| 2023 | 162 |
| 2024 | 222 |
| 2025 | 266 |
| 2026 | 244 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Athlete's foot.
Crawford F · BMJ Clin Evid 2009 · Systematic Review
- Chemoprophylaxis of fungal deterioration of the Provox silicone tracheoesophageal prosthesis in postlaryngectomy patients.
van Weissenbruch R, Bouckaert S, Remon JP, et al. · Ann Otol Rhinol Laryngol 1997 · Clinical Trial, Comparative Study
- Monistat cream (miconazole nitrate) a new agent for the treatment of vulvovaginal candidiasis.
Qualey JR, Cooper C · J Reprod Med 1975 · Clinical Trial, Comparative Study
- Evaluation of Monistat cream (miconazole nitrate 2%) in a reduced regimen for the treatment of vulvovaginal candidiasis.
Sargent EC, Pasquale SA · J Reprod Med 1977 · Clinical Trial, Randomized Controlled Trial
- Residual antibacterial activity of canine hair treated with topical antimicrobial sprays against Staphylococcus pseudintermedius in vitro.
Mesman ML, Kirby AL, Rosenkrantz WS, et al. · Vet Dermatol 2016 · Clinical Trial
- Treatment of vaginitis.
Kükner S, Ergin T, Ciçek N, et al. · Int J Gynaecol Obstet 1996 · Clinical Trial
Sponsor: Medtech Products · Also marketed as Monistat 3 Combination Pack (Prefilled)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.